Furthermore, a study by Ma et al. (2025) showcased the role of SLC26A9 in breast cancer, indicating that it promotes tumor cell proliferation and metastasis through the PI3K/AKT signaling pathway (Ma et al., 2025). This evidence concerns the gene SLC26A9 and breast carcinoma.